Buy Acorda Therapeutics Stock | ACOR Stock Price & Latest News | Public.com
ACOR

Acorda Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Acorda Therapeutics (ACOR) stock trends here

    About ACOR

    Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nal...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.32
    -3.06
    -6.44
    -9.82
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$2.76

    Actual EPS
    Q2 2021

    Stats

    Market Cap$39,76M
    Volume105,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.84
    1 Year Low$2.53
    Open$3.95
    High$4.33
    Low$3.91

    Buy any stock with any amount of money.

    Download the App
    Download the app